Antani, Abraham B.
HRN: 21-93-42 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/24/2022
10/02/2022
IVTT
712mg
Q6
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes